Observational Study of Liver Transplant for Colorectal Cancer Metastases
This study is looking at different ways doctors perform liver transplants for people whose colorectal cancer has spread to their liver (colorectal cancer liver metastases or CRLM). The goal is to compare the results of various standard transplant methods, such as using a living or deceased donor, or a whole or split liver. Researchers will observe how patients recover in the hospital and how long they survive after the transplant, up to one year. They will also collect blood samples for future research. You may be able to join if you are 18 or older, are listed for a liver transplant at Northwestern due to CRLM, and can give your own informed consent. This is an observational study, meaning doctors are watching and comparing existing treatments, not testing new ones.
- Study design
- This is an observational study planning to enroll 80 participants. It will compare different standard liver transplant methods.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed from the time of their liver transplant up to 12 months to assess graft and patient survival.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Graft and Patient Survival OutcomesFrom liver transplant to 12 months
Graft survival will be measured as the time from transplantation to graft failure, or re-transplantation date.